EDIT · Editas Medicine, Inc.
AI read · Good for EDIT
The AI's read
That gives Editas a path to test whether EDIT-401 can help people with high cholesterol. Monkey studies showed large drops in several harmful blood fats, and one drop lasted 10 months. Those results have not yet been shown in people. Human safety and benefit remain unknown, New Zealand review is pending, and the company warns that its cash may not cover future costs. The chance to begin testing, backed by promising animal results, makes the news positive for Editas.